Back
Xtacy Therapeutics Vs. MedBright AI Investments Industry Stock Comparison
Sell
16
XTCY.CX
Xtacy Therapeutics
Last Price:
0.02
Seasonality Move:
-17.84%
Sell
27
MBAI.CX
MedBright AI Investments
Last Price:
0.05
Seasonality Move:
44.21%
Sell
16
Xtacy Therapeutics (XTCY.CX)
is a Sell
Is Xtacy Therapeutics a Buy, Sell or Hold?
- The current Xtacy Therapeutics [XTCY.CX] share price is $0.02. The Score for XTCY.CX is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
- XTCY.CX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
27
MedBright AI Investments (MBAI.CX)
is a Sell
Is MedBright AI Investments a Buy, Sell or Hold?
- The current MedBright AI Investments [MBAI.CX] share price is $0.05. The Score for MBAI.CX is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- MBAI.CX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
XTCY.CX Stock Price Chart
What is Xtacy Therapeutics's stock price today?
-
The Xtacy Therapeutics share price today is $0.02
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XTCY.CX is experiencing slight buying pressure.
MBAI.CX Stock Price Chart
What is MedBright AI Investments's stock price today?
-
The MedBright AI Investments share price today is $0.05
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MBAI.CX is experiencing slight buying pressure.
XTCY.CX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 34.43 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.02 - 0.02) | Sell |
| Bollinger Bands (100): | (0.02 - 0.04) | Sell |
MBAI.CX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 41.08 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.05 - 0.07) | Sell |
| Bollinger Bands (100): | (0.06 - 0.1) | Sell |
XTCY.CX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.02 | Sell |
| 20-day SMA: | 0.02 | Sell |
| 50-day SMA: | 0.03 | Sell |
| 200-day SMA: | 0.04 | Sell |
| 8-day EMA: | 0.02 | Sell |
| 20-day EMA: | 0.02 | Sell |
| 50-day EMA: | 0.03 | Sell |
| 200-day EMA: | 0.04 | Sell |
MBAI.CX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.06 | Sell |
| 20-day SMA: | 0.06 | Sell |
| 50-day SMA: | 0.07 | Sell |
| 200-day SMA: | 0.13 | Sell |
| 8-day EMA: | 0.06 | Sell |
| 20-day EMA: | 0.06 | Sell |
| 50-day EMA: | 0.07 | Sell |
| 200-day EMA: | 0.11 | Sell |
Xtacy Therapeutics Earnings Growth & XTCY.CX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
MedBright AI Investments Earnings Growth & MBAI.CX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Xtacy Therapeutics Technical Analysis
| Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 08 | 09 | 10 | 11 | 15 | 16 | 18 | 21 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
MedBright AI Investments Technical Analysis
| Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 08 | 09 | 10 | 11 | 15 | 16 | 18 | 21 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||